Cicero AF; Derosa G; Manca M; Bove M; Borghi C; Gaddi AV., Different effect of psyllium and guar dietary supplementation on blood pressure control in hypertensive overweight patients: a six-month, randomized clinical trial., «CLINICAL AND EXPERIMENTAL HYPERTENSION», 2007, 29, pp. 383 - 394 [Scientific article]
Laghi, L; Cicero, AFG; Derosa, G; Manca, M; Bove, M; Borghi, C; Gaddi, AV, Efficacy of soluble fiber supplementation in CVD risk management of patients affected by metabolic syndrome: A 6-months, open-label, RCT, «ATHEROSCLEROSIS SUPPLEMENTS», 2007, 8, pp. 169 - 169 [Abstract]
Derosa, G; Cicero, AFG; D'Angelo, A; Celentano, C; Fiorenza, AM; Salvadeo, SAT; Pricolo, F; Ferrari, I; Gravina, A; Fogari, R, Inflammation markers and MMPS in nondiabetic and diabetic subjects OGTT, «ATHEROSCLEROSIS SUPPLEMENTS», 2007, 8, pp. 66 - 67 [Abstract]
Manca, M; Cicero, AFG; Laghi, L; Bove, M; Borghi, C; Gaddi, AV, Influence of metabolic syndrome superposition on familial combined hyperlipoproteinemia cardiovascular complication rate, «ATHEROSCLEROSIS SUPPLEMENTS», 2007, 8, pp. 38 - 38 [Abstract]
Borghi c; Veronesi M; Cosentino E; Cicero AF; Kuria F; Dormi A; Ambrosioni E., Interaction between serum cholesterol levels and the renin-angiotensin system on the new onset of arterial hypertension in subjects with high-normal blood pressure., «JOURNAL OF HYPERTENSION», 2007, 25, pp. 2051 - 2057 [Scientific article]
Cicero, AFG; Derosa, G; Manca, M; Bove, M; Borghi, C; Gaddi, AV, MMP-2, MMP-9 and their inhibitors and other prothrombotic risk factors plasma level in FCH, MS, FCH plus MS and control subjects, «ATHEROSCLEROSIS SUPPLEMENTS», 2007, 8, pp. 94 - 94 [Abstract]
Prandin MG; Cicero AF; Veronesi M; Cosentino E; Dormi A; Strocchi E; Borghi C, Persistence on treatment and blood pressure control with different first-line antihypertensive treatments: a prospective evaluation., «CLINICAL AND EXPERIMENTAL HYPERTENSION», 2007, 29, pp. 553 - 562 [Scientific article]
Gaddi A, Cicero AF, Odoo FO, Poli AA, Paoletti R; Atherosclerosis and Metabolic Diseases Study Group., Practical guidelines for familial combined hyperlipidemia diagnosis: an up-date., «VASCULAR HEALTH AND RISK MANAGEMENT», 2007, 3, pp. 877 - 886 [Scientific article]Open Access
Bove M, Cicero AF, Manca M, Georgoulis I, Motta R, Giovannini M, Poggiopollini G, Gaddi AV., Sources of variability of plasma HDL-cholesterol levels., «FUTURE LIPIDOLOGY», 2007, 2, pp. 557 - 569 [Scientific article]
Bove M; Cicero AFG; Manca M; Georgoulis I; Motta R; Giovannini M; Poggiopollini G; Gaddi AV., Sources of variabilità of plasma HDL-cholesterol levels., «FUTURE LIPIDOLOGY», 2007, 2(5), pp. 557 - 569 [Scientific article]
Gaddi AV; Cicero AFG, Strumenti diagnostici per l’identificazione delle iperlipoproteinemie a base genetica., 2007. [Software]
Cicero AF; Derosa G; Manca M; Bove M; Borghi C; Gaddi AV., Vascular remodeling and prothrombotic markers in subjects affected by familial combined hyperlipidemia and/or metabolic syndrome in primary prevention for cardiovascular disease., «ENDOTHELIUM», 2007, 14, pp. 193 - 198 [Scientific article]
Bove M.; Cicero A.F.G.; Derosa G.; Borghi C.; Manca M.; Gaddi A.V., A comparison study of Lp(a) plasma levels distributions between normo- and hypertensive subjects with high BMI., in: , «NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES», 2006, 16(S1), pp. 3 - 3 (atti di: SISA Nazionale, Bologna, Novembre 2006) [Abstract]
Micali S.; Sighinolfi M.C.; De Stefani S.; Grande M.; Cicero A.; Bianchi G., Can Phyllantus niruri (Uriston ®) affect the efficacy of extracorporeal shock wave lithiotrispy or renal stones. A randomised, prospective, long-term study., «THE JOURNAL OF UROLOGY», 2006, 176, pp. 1020 - 1022 [Scientific article]
Sighinolfi M.C.; Mofferdin A.; De Stefani S.; Celia A.; Micali S.; Cicero A.; Bianchi G., Changes in peak systolic velocity induced by chronic therapy with phosphodiesterase type 5 inhibitor., «ANDROLOGIA», 2006, 38, pp. 84 - 86 [Scientific article]
